At one month, follow-up CT at matched anatomic levels showed interval tumor shrinkage with decreased arterial-phase hyperenhancement, and AFP and PIVKA-II had fallen to within the institutional reference ranges (Figure 4). Here, AFP is linked to neoplasm.